New England Research & Management, Inc. Organon & Co. Transaction History
New England Research & Management, Inc.
- $213 Million
- Q3 2024
A detailed history of New England Research & Management, Inc. transactions in Organon & Co. stock. As of the latest transaction made, New England Research & Management, Inc. holds 16,092 shares of OGN stock, worth $235,586. This represents 0.14% of its overall portfolio holdings.
Number of Shares
16,092
Previous 16,844
4.46%
Holding current value
$235,586
Previous $349,000
11.75%
% of portfolio
0.14%
Previous 0.17%
Shares
9 transactions
Others Institutions Holding OGN
# of Institutions
793Shares Held
192MCall Options Held
1.71MPut Options Held
865K-
Black Rock Inc. New York, NY32.6MShares$477 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$442 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.76MShares$143 Million0.06% of portfolio
-
State Street Corp Boston, MA8.98MShares$131 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL7.49MShares$110 Million0.31% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $3.72B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...